Segment - Schedule of Segment Reporting Information by Segment (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Operating expenses:
Share-based compensation expense	$ 11,633	$ 4,530
Interest and other expense	8	300
Reconciliation of loss:
Interest income	(3,441)	(2,013)
Adjustments and reconciling items	(3,441)	(2,013)
Net loss	59,517	52,673
Clinical Research Segment [Member]
Operating expenses:
Direct program expense	28,373	27,398
Indirect program expense	1,923	2,157
Workforce salaries and benefits	16,301	15,102
Share-based compensation expense	11,633	4,530
General corporate expenses	4,720	5,199
Interest and other expense	8	300
Reconciliation of loss:
Net loss	$ 62,958	$ 54,686